Literature DB >> 4646289

Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics.

L Agostini, P F Down, J Murison, O M Wrong.   

Abstract

The effect of lactulose on faecal pH and ammonia has been studied in three normal subjects with the aid of dialysis of faeces in vivo. Observations were also made with sodium sulphate and the two hexahydric alcohols, mannitol and sorbitol, given in doses sufficient to cause a similar increase in stool weight. All four cathartics rendered the stool more acid, but there was no increase in the concentration of faecal ammonia. Lactulose, despite increasing faecal volume, did not cause an increase in the absolute amount of ammonia lost in the faeces, but the other purgatives did show a modest rise. The results are inconsistent with the theory that lactulose benefits the clinical picture of portosystemic encephalopathy by trapping ammonia in an acid stool. An alternative suggestion is advanced, namely, that any cathartic (including lactulose) reduces ammonia absorption from the colon by decreasing colonic transit time, and so reducing the amount of ammonia generated by autolysis of colonic bacteria.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4646289      PMCID: PMC1412409          DOI: 10.1136/gut.13.11.859

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  A controlled clinical trial of lactulose in hepatic encephalopathy.

Authors:  F Simmons; H Goldstein; J D Boyle
Journal:  Gastroenterology       Date:  1970-12       Impact factor: 22.682

2.  Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

Authors:  S G Elkington; M H Floch; H O Conn
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

3.  Encephalopathy after portacaval shunting managed with lactulose.

Authors:  H Brown; C Trey; W V McDermott
Journal:  Am J Surg       Date:  1970-02       Impact factor: 2.565

4.  Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.

Authors:  R Zeegen; J E Drinkwater; J C Fenton; A Vince; A M Dawson
Journal:  Q J Med       Date:  1970-04

5.  Clinical significance of intraluminal pH in intestinal ammonia transport.

Authors:  J B Price; M Sawada; A B Voorhees
Journal:  Am J Surg       Date:  1970-05       Impact factor: 2.565

6.  Lactulose treatment of hepatic encephalopathy in outpatients.

Authors:  H Brown; C Trey; W V McDermott
Journal:  Arch Surg       Date:  1971-01

7.  Long-term treatment of portal-systemic encephalopathy with lactulose.

Authors:  M H Ma; J G McLeod; C R Blackburn
Journal:  Australas Ann Med       Date:  1969-05

8.  Wrong idea, good results (the lactulose story).

Authors:  U P Haemmerli; J Bircher
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

9.  Treatment of chronic portal-systemic encephalopathy with lactulose.

Authors:  J Bircher; J Müller; P Guggenheim; U P Haemmerli
Journal:  Lancet       Date:  1966-04-23       Impact factor: 79.321

10.  In vivo dialysis of faeces as a method of stool analysis. II. The influence of diet.

Authors:  A Metcalfe-Gibson; T S Ing; J J Kuiper; P Richards; E E Ward; O M Wrong
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124

View more
  14 in total

Review 1.  Some aspects of medical management of gastrointestinal disease. I.

Authors:  B W Badley
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

Review 2.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Regulation of blood ammonia.

Authors:  A M Dawson
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

4.  Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.

Authors:  N J Greenberger; J Carley; S Schenker; I Bettinger; C Stamnes; P Beyer
Journal:  Am J Dig Dis       Date:  1977-10

Review 5.  Hepatic encephalopathy.

Authors:  M S Losowsky; B B Scott
Journal:  Br Med J       Date:  1973-08-04

Review 6.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

7.  Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Authors:  C E Atterbury; W C Maddrey; H O Conn
Journal:  Am J Dig Dis       Date:  1978-05

8.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

9.  Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.

Authors:  D H Patil; D Westaby; Y R Mahida; K R Palmer; R Rees; M L Clark; A M Dawson; D B Silk
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

10.  Management of hepatic encephalopathy.

Authors:  G Wright; A Chattree; R Jalan
Journal:  Int J Hepatol       Date:  2011-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.